Efficacy measures included : mean change in nocturia at 24 months ; proportion of patients with improvement/worsening in nocturia ; nocturnal voiding frequency at baseline and study end , overall and by baseline subgroups ; and nocturnal voiding frequency < 2 at study end in patients with baseline score 2 .